Table 2 lists TEAEs that were more common (P ≤ .05) in GH-treated than in untreated patients, after adjusting for baseline differences. After application of the FDR criteria (P ≤ .05 and FDR-adjusted P ≤ .1), most expected TEAEs were retained as probable true positives, with the exception of joint swelling, joint stiffness, and acne. This evidence concerns the gene GH1 and acne.